共 225 条
[11]
Kwon JS(2010)Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies Lancet 375 2215-2222
[12]
Lee Y(2016)Oxidative stress, inflammation, endothelial dysfunction and incidence of type 2 diabetes Cardiovasc Diabetol. 15 51-716
[13]
Liu S(2017)Target organ damage and incident type 2 diabetes mellitus: the Strong Heart Study Cardiovasc Diabetol. 16 64-1131
[14]
Veronese N(2010)High-sensitivity C-reactive protein predicts cardiovascular risk in diabetic and nondiabetic patients: effects of insulin-sensitizing treatment with pioglitazone J Diabetes Sci Technol. 4 706-S309
[15]
Cereda E(2016)Association of soluble tumor necrosis factor receptors 1 and 2 with nephropathy, cardiovascular events, and total mortality in type 2 diabetes Cardiovasc Diabetol. 15 40-247
[16]
Stubbs B(2014)Adiponectin: a manifold therapeutic target for metabolic syndrome, diabetes, and coronary disease? Cardiovasc Diabetol. 13 103-326
[17]
Solmi M(2017)Neutrophil gelatinase associated lipocalin (NGAL) is elevated in type 2 diabetics with carotid artery stenosis and reduced under metformin treatment Cardiovasc Diabetol. 16 98-1158
[18]
Luchini C(2017)Mirroring the CANTOS revolution: is anti-inflammatory therapy for diabetes just around the corner? Cardiovasc Diabetol. 16 91-312
[19]
Manzato E(2017)Antiinflammatory therapy with canakinumab for atherosclerotic disease N Engl J Med 377 1119-239
[20]
Simon A(2018)Anti-inflammatory therapy with canakinumab for the prevention and management of diabetes J Am Coll Cardiol 11 S307-27